Favorable responses to acute and chronic exercise in McArdle patients

Clinical Journal of Sport Medicine

Volumn 17, Issue 4, 2007, Pages 297-303

  Maté Muñoz, José L ^a   Moran, Maria ^b   Pérez, Margarita ^a   Chamorro Viña, Carolina ^a   Gómez Gallego, Félix ^a   Santiago, Catalina ^a   Chicharro, Luis ^a   Foster, Carl ^c   Nogales Gadea, Gisela ^d,e   Rubio, Juan C ^b,e   Andreu, Antoni L ^d   Martín, Miguel A ^b,e   Arenas, Joaquín ^b,e   Lucia, Alejandro ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Glycogenosis type V; Myophosphorylase; VO2peak; VT

Indexed keywords

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BIOCHEMISTRY; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; ERGOMETRY; EXERCISE PHYSIOLOGY; FEMALE; GENETIC ANALYSIS; GLYCOGEN STORAGE DISEASE TYPE 5; HISTOCHEMISTRY; HUMAN; KINESIOTHERAPY; LIFESTYLE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; STEADY STATE; WALKING;

ADOLESCENT; ADULT; AGED; BLOOD CHEMICAL ANALYSIS; EXERCISE; EXERCISE TEST; EXERTION; FEMALE; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OXYGEN CONSUMPTION; SPAIN;

EID: 34447336686     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e3180f6168c     Document Type: Article

References (27)

1. McArdle B. Myophaty due to a defect in muscle glycogen breakdown. Clin Sci. 1951;10:13-33.
2. Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease). N Engl J Med. 1993;329:241-245.
3. Martin MA, Rubio JC, Buchbinder J, et al. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol. 2001;50:574-581.
4. Rubio JC, Nogales-Gadea G, Garcia-Consuegra I, et al. A proposed molecular diagnosis flowchart for myophopshorylase deficiency (McArdle disease) in blood samples from Spanish patients. Hum Mutat. 2007;28:203-204.
5. Haller RG, Wyrick P, Taivassalo T, et al. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol. 2006;59:922-928.
6. Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med. 2003;349:2503-2509.
7. Vorgerd M, Grehl T, Jager M, et al. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol. 2002;57:956-963.
8. Vorgerd M, Zange J, Kley R, et al. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch Neurol. 2002;59:97-101.
9. Lucia A, Maté-Muñoz JL, Pérez M, et al. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help? Muscle Nerve. 2007;35:125-128.
10. Perez M, Martin MA, Rubio JC, et al. Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising. Br J Sports Med. 2006;40:725-726.
11. Pérez M, Maté-Muñoz JL, Foster C, et al. Exercise capacity in a child with McArdle's disease. J Child Neurol. (in press).
12. Pérez M, Morán M, Cardona C, et al. Can McArdle's patients run? A case report. Br J Sports Med. 2007;41:53-54.
13. Pérez M, Martin MA, Cañete S, et al. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly? Int J Sports Med. 2006;27:429-435.
14. San Juan AF, Gómez-Gallego F, Cañete S, et al. Does complete deficiency of α-actinin-3 alter functional capacity in elderly women? A preliminary report. Br J Sports Med. 2006;40:e1.
15. Lucia A, Vaquero AF, Perez M, et al. Electromyographic response to exercise in cardiac transplant patients: a new method for anaerobic threshold determination? Chest. 1997;111:1571-1576.
16. San Juan AF, Fleck SJ, Chamorro-Viña C, et al. Effects of an intra-hospital exercise program intervention for children with leukemia. Med Sci Sports Exerc. 2007;39:13-21.
17. Chavarren J, Calbet JAL. Cycling efficiency and pedalling frequency in road cyclists. Eur J Appl Physiol Occup Physiol. 1999;80:555-563.
18. Sorichter S, Puschendorf B, Mair J. Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exerc Immunol Rev. 1999;5:5-21.
19. Adams JE 3rd, Bodor GS, Davila-Roman VG, et al. A marker with high specificity for cardiac injury. Circulation. 1993;88:101-106.
20. American College of Sports Medicine. Position stand on the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30:975-991.
21. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;4:793-801.
22. McArdle WD, Katch FI, Katch VL. Exercise Physiology. Energy, Nutrition and Performance. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
23. Meyer T, Lucia A, Earnest CP, et al. A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters - theory and application. Int J Sports Med. 2005;26(Suppl 1):S38-S48.
24. Baarends EM, Schols AM, Akkermans MA, et al. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax. 1997;52:981-986.
25. Coyle EF, Sidossis LS, Horowitz JF, et al. Cycling efficiency is related to the percentage of type I muscle fibers. Med Sci Sports Exerc. 1992;24:782-788.
26. Nybo L, Dalsgaard MK, Steensberg A, et al. Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol. 2005;563:285-290.
27. Stein TP, Wade CE. Protein turnover in atrophying muscle: from nutritional intervention to microarray expression analysis. Curr Opin Clin Nutr Metab Care. 2003;6:95-102.